Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Catalent to acquire Metrics Contract Services for $475 million

by Rick Mullin
August 14, 2022 | A version of this story appeared in Volume 100, Issue 28

 

Catalent says it will expand its oral-dose drug development and manufacturing services with the acquisition of Metrics Contract Services from Mayne Pharma for $475 million. Metrics specializes in production and packaging of high-potency drugs. Its Greenville, North Carolina, facility features 16 manufacturing suites and two packaging lines with an annual production capacity of about 1 billion oral solid-dose units. Catalent already operates a controlled-release oral-dose drug plant in Winchester, Kentucky, and a softgel facility in St. Petersburg, Florida.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.